Gas-Amplified Metalloimmunotherapy enhances immune responses against cervical cancer by inducing pyroptosis and activating the STING pathway to remodel the tumor’s immunosuppressive microenvironment. The gene discussed is STING1; the disease is cervical carcinoma.